Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
alnylam pharmaceuticals
5
×
boston
5
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
5
×
fda
hereditary transthyretin amyloidosis
new york blog main
patisiran
rna interference
akcea therapeutics
clinical trials
inotersen
new york top stories
san diego blog main
san diego top stories
san francisco blog main
tafamidis
barry greene
biotech
craig mello
dan ollendorf
drugs
harvard pilgrim health care
institute for clinical and economic review
onpattro
pfizer
san francisco top stories
vyndaqel
alexion pharmaceuticals
amy schulman
andreas klein
andrew fire
anna greka
boehringer ingelheim
boston university
car-t
caron jacobson
What
alnylam
drug
fda
gene
medicine
rna
interference
medicines
pharmaceuticals
protein
rnai
uses
afternoon
ago
alnylam’s
approve
approved
approves
aren’t
awaits
biological
car
caught
causing
cells
crossed
cutting
decades
decision
dicerna
discovered
disease
edge
ema
employ
europe
experiments
eye
fingers
follows
Language
unset
Current search:
photo
×
boston
×
" national top stories "
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”